Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (72 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > What Is It We Are Waiting For
View:
Post by toade1313 on Aug 23, 2024 8:17am

What Is It We Are Waiting For

With all the delays for filing the preBTD what is it exactly that we are waiting for?

Data from just 1 institution or multiple institutions?

Data for just 1 patient from just 1 institution or multiple patients from just 1 institution?

Data from just 1 patient from multiple institutions?

Data from multiple patients from multiple institutions.

Obviously Theralase can not control getting the data from the institution(s) but to date they have not done a very good job estimating when they will get the data. I wish they would share with us exactly what they are waiting for.
Comment by tdon1229 on Aug 23, 2024 9:17am
Just a reminder that Theralase is only sponsoring the clinical trial, not running it.  They contracted others to conduct the trial for them.   Each clinic has its own PI and practitioners.  Theralase does not provide the PIs and the practitioners with fulltime employment. They work under contract as the need arises for their services.   With so many links in the chain, it& ...more  
Comment by riverrrow on Aug 23, 2024 9:19am
Now that the tradeable warrants have expired at a capital loss of 7 cents a warrant for those still holding their warrants received at the initial financing, lets see that much hyped second tranche of pp get filled.  As if.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250